A Ranki

Author PubWeight™ 101.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999 5.01
2 Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection. Lancet 1987 3.68
3 Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets. Cell Immunol 1979 1.94
4 Identification of resting human T and B lymphocytes by acid alpha-naphthyl acetate esterase staining combined with rosette formation with Staphylococcus aureus strain Cowan 1. Scand J Immunol 1976 1.91
5 Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. Proc Natl Acad Sci U S A 1987 1.70
6 Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets. Immunol Rev 1979 1.58
7 Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun 1999 1.48
8 Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056). Br J Dermatol 2012 1.46
9 Significance of restricted HIV expression for HIV neuropathogenesis: still an unresolved issue. AIDS 1997 1.41
10 Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men. Proc Natl Acad Sci U S A 1987 1.37
11 [Mystery of the blue man: alkaptonuria]. Duodecim 1997 1.37
12 European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006 1.30
13 Characterization of the immunocompetent cells of rheumatoid synovium from tissue sections and eluates. Arthritis Rheum 1981 1.17
14 Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis). J Invest Dermatol 1984 1.17
15 High rates of disseminated infection due to non-tuberculous mycobacteria among AIDS patients in Finland. J Infect 1999 1.15
16 Human natural cell-mediated cytotoxicity against fetal fibroblasts. III. Morphological and functional characterization of the effector cells. Cell Immunol 1979 1.15
17 Diversity of clinical spectrum of HTLV-III infection. Lancet 1985 1.12
18 Nonspecific esterase activity in human lymphocytes. Histochemical characterization and distribution among major lymphocyte subclasses. Clin Immunol Immunopathol 1978 1.11
19 The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. International MAC Study Group. AIDS 1996 1.09
20 Allelic variants in genes associated with hereditary periodic fever syndromes as susceptibility factors for reactive systemic AA amyloidosis. Genes Immun 2004 1.09
21 Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1. J Immunol 1988 1.08
22 The optimal use of bexarotene in cutaneous T-cell lymphoma. Br J Dermatol 2007 1.06
23 Cellular localization of Nef expressed in persistently HIV-1-infected low-producer astrocytes. AIDS 1992 1.03
24 Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions. J Infect Dis 1993 1.03
25 Identification of mouse T and B lymphocytes from cytocentrifuged cell smears. Clin Exp Immunol 1976 1.01
26 Immune functions in homosexual men with antibodies to HTLV-III in Finland. Clin Exp Immunol 1985 0.95
27 Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion. Br J Dermatol 2006 0.93
28 Immunological variation and immunohistochemical localization of HIV-1 Nef demonstrated with monoclonal antibodies. AIDS 1992 0.93
29 Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations. Lupus 2008 0.93
30 Evidence against keratin gene mutations in a family with ichthyosis hystrix Curth-Macklin. J Invest Dermatol 1993 0.93
31 Expression of the acid alpha-naphthyl acetate esterase marker by activated and secondary T lymphocytes in man. Scand J Immunol 1977 0.93
32 Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings. Br J Dermatol 1997 0.92
33 A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study Group. AIDS 1994 0.92
34 Infrequent p53 mutations in arsenic-related skin lesions. Oncol Res 1998 0.91
35 Lack of subclass selection during density purification of human lymphocytes. Clin Exp Immunol 1977 0.91
36 Interpretation of antibodies reacting solely with human retroviral core proteins. N Engl J Med 1988 0.90
37 An improved enrichment method for functionally competent, highly purified peripheral blood dendritic cells and its application to HIV-infected blood samples. Clin Exp Immunol 1993 0.89
38 Disease associations in polymorphous light eruption. A long-term follow-up study of 94 patients. Arch Dermatol 1998 0.89
39 Prolonged exclusive breastfeeding is associated with increased atopic dermatitis: a prospective follow-up study of unselected healthy newborns from birth to age 20 years. Clin Exp Allergy 2006 0.88
40 Lymphocytes and Langerhans cells in patch tests. An immunohistochemical and electron microscopic study. Contact Dermatitis 1984 0.88
41 Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma. J Invest Dermatol 2000 0.88
42 Assessing physicians' preferences on skin cancer treatment in Europe. Br J Dermatol 2012 0.87
43 Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study. Br J Dermatol 2012 0.87
44 Prevention of flower development in birch and other plants using a BpFULL1::BARNASE construct. Plant Cell Rep 2005 0.87
45 Serological responses to mycoplasmas in HIV-infected and non-infected individuals. AIDS 1992 0.86
46 Accumulation of matrilysin (MMP-7) and macrophage metalloelastase (MMP-12) in actinic damage. J Invest Dermatol 1999 0.86
47 Risk factors for actinic keratosis in eight European centres: a case-control study. Br J Dermatol 2012 0.85
48 Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol 2014 0.85
49 Potential role of a navigator gene NAV3 in colorectal cancer. Br J Cancer 2011 0.85
50 Mutational analysis of the HGO gene in Finnish alkaptonuria patients. J Med Genet 1999 0.84
51 Presence of alpha-naphthyl acetate esterase activity in human haematopoietic cell lines and in fresh biopsy specimens of lymphoma and myeloma. Scand J Haematol 1978 0.84
52 Antigenic epitopes of NEF proteins from different HIV-1 strains as recognized by sera from patients with manifest and latent HIV infection. Virology 1990 0.84
53 Polymorphism of the tumor necrosis factor genes in patients with dermatitis herpetiformis. Dermatology 1994 0.84
54 Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis. Br J Dermatol 2001 0.83
55 Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein. Int J Cancer 1998 0.83
56 Notable losses at specific regions of chromosomes 10q and 13q in the Sézary syndrome detected by comparative genomic hybridization. J Invest Dermatol 1999 0.82
57 Maintenance therapy in cutaneous T-cell lymphoma: who, when, what? Eur J Cancer 2007 0.82
58 Serum cholesterol level in infancy is inversely associated with subsequent allergy in children and adolescents. A 20-year follow-up study. Clin Exp Allergy 2007 0.82
59 Selective responses of mouse T lymphocytes to different T mitogens and in mixed lymphocyte culture induced cytolysis reaction. Cell Immunol 1976 0.82
60 RANTES, MIP and interleukin-16 in HIV infection. AIDS 1996 0.82
61 Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev. AIDS Res Hum Retroviruses 1995 0.81
62 T and B lymphocytes, macrophages and Langerhans' cells during the course of contact allergic and irritant skin reactions in man. Acta Derm Venereol 1983 0.81
63 T lymphocyte subclasses in rheumatoid synovia as analysed with monoclonal antibodies and functional in vitro tests. Scand J Rheumatol 1984 0.81
64 Interleukin-10 gene expression induced by HIV-1 Tat and Rev in the cells of HIV-1 infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1996 0.81
65 Oral candidal infection as a sign of HIV infection in homosexual men. Oral Surg Oral Med Oral Pathol 1988 0.80
66 B-cell epitopes in HIV-1 Tat and Rev proteins colocalize with T-cell epitopes and with functional domains. Biomed Pharmacother 1997 0.80
67 The validity of immunological studies in human immunodeficiency virus infection: a three-year follow-up of 235 homo- or bisexual persons. Acta Pathol Microbiol Immunol Scand C 1987 0.80
68 Further characterization of the effector cell responsible for natural cytotoxicity to chicken erythrocytes in man. Eur J Immunol 1978 0.80
69 Molecular cytogenetics in the study of cutaneous T-cell lymphomas (CTCL). Cytogenet Genome Res 2007 0.80
70 Distribution of naive and memory T-cells in photoprovoked and spontaneous skin lesions of discoid lupus erythematosus and polymorphous light eruption. Acta Derm Venereol 1999 0.80
71 Serum immunoglobulin A concentration in infancy, but not human milk immunoglobulin A, is associated with subsequent atopic manifestations in children and adolescents: a 20-year prospective follow-up study. Clin Exp Allergy 2011 0.80
72 Histochemical distinction between lymphocytic and monocytic acid alpha-naphthyl acetate (ANAE) esterases. J Clin Lab Immunol 1979 0.79
73 In vitro T- and B-cell reactivity in cartilage hair hypoplasia. Clin Exp Immunol 1978 0.79
74 Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology Forum. J Eur Acad Dermatol Venereol 2005 0.79
75 Immunoperoxidase identification of intracellular immunoglobulins from cell smears. Am J Clin Pathol 1980 0.79
76 Matrix metalloproteinases as mediators of tissue injury in different forms of cutaneous lupus erythematosus. Br J Dermatol 2007 0.79
77 The relation of different inflammatory cell types to the various parenchymal components of rejecting kidney allografts. Histopathology 1980 0.79
78 T lymphocytes and mononuclear phagocytes in the skin infiltrate of systemic and discoid lupus erythematosus and Jessner's lymphocytic infiltrate. Br J Dermatol 1981 0.79
79 Langerhans cell--mononuclear cell contacts are not specific for allergy in patch tests. Br J Dermatol 1983 0.78
80 Lymphocytes and Langerhans cells in allergic patch tests. Derm Beruf Umwelt 1987 0.78
81 Affinity-based collection of amplified viral DNA: application to the detection of human immunodeficiency virus type 1, human cytomegalovirus and human papillomavirus type 16. Mol Cell Probes 1990 0.78
82 Fractionation of immunocompetent cells by free-flow cell electrophoresis. Isr J Med Sci 1975 0.78
83 Zidovudine reduces intrathecal immunoactivation in patients with early human immunodeficiency virus type 1 infection. Arch Neurol 1994 0.77
84 Polyclonal B-cell activation and increased lymphocyte helper-suppressor ratios in discoid lupus erythematosus. Br J Dermatol 1984 0.77
85 Helper T-cell recognition of HIV-1 Tat synthetic peptides. J Acquir Immune Defic Syndr 1993 0.77
86 The genetic background of tumour necrosis factor receptor-associated periodic syndrome and other systemic autoinflammatory disorders. Scand J Rheumatol 2004 0.77
87 Immunosuppression in homosexual men seronegative for HTLV-III. Cancer Res 1985 0.77
88 Retinol concentrations after birth are inversely associated with atopic manifestations in children and young adults. Clin Exp Allergy 2007 0.77
89 Erythema elevatum diutinum in association with coeliac disease. Br J Dermatol 1997 0.77
90 Occurrence of polymorphous light eruption in lupus erythematosus. Br J Dermatol 1997 0.77
91 Chromosomal abnormalities in relation to clinical disease in patients with cutaneous T-cell lymphoma: a 5-year follow-up study. Br J Dermatol 2003 0.76
92 Distribution of natural killer cells and lymphocyte subclasses in Jessner's lymphocytic infiltration of the skin and in cutaneous lesions of discoid and systemic lupus erythematosus. Br J Dermatol 1987 0.76
93 Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings. J Med Primatol 1989 0.76
94 DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector. Vaccine 2001 0.76
95 The patient journey: a report of skin cancer care across Europe. Br J Dermatol 2012 0.76
96 A novel tumour necrosis factor receptor mutation in a Finnish family with periodic fever syndrome. Scand J Rheumatol 2004 0.76
97 T-cell recognition of HIV antigens in HIV-seroreverted persons. AIDS 1997 0.76
98 A comparison of histopathologic diagnosis and the demonstration of human papillomavirus-specific DNA and proteins in penile warts. Sex Transm Dis 1992 0.76
99 Chromosomal abnormalities in cutaneous T-cell lymphoma and in its premalignant conditions as detected by G-banding and interphase cytogenetic methods. J Invest Dermatol 1997 0.76
100 Simultaneously detected aberrant p53 tumor suppressor protein and HPV-DNA localize mostly in separate keratinocytes in anogenital and common warts. Exp Dermatol 1996 0.76
101 H. influenzae vaccines in HIV. N Engl J Med 1992 0.75
102 Cell-mediated immune response to human immunodeficiency virus in homosexual men. J Infect Dis 1993 0.75
103 Effect of etretinate on the distribution of Langerhans cells and T. lymphocytes in psoriatic skin. Arch Dermatol Res 1984 0.75
104 Humoral and cellular immune responses to HIV-1 nef in mice DNA-immunised with non-replicating or self-replicating expression vectors. Vaccine 1999 0.75
105 Distribution of four subclass-specific lymphocyte markers in man. Acta Pathol Microbiol Scand C 1978 0.75
106 [HIV infection in Finland]. Katilolehti 1987 0.75
107 Carbon dioxide (CO2)-laser therapy cures macroscopic lesions, but viral genome is not eradicated in men with therapy-resistant HPV infection. Sex Transm Dis 1995 0.75
108 [Mutation of the cytokine receptor behind periodical fever syndrome]. Duodecim 1999 0.75
109 [Lymphomatoid papulosis--a sheep in wolves' clothes]. Duodecim 2001 0.75
110 HIV-1 specificity of cerebrospinal fluid and serum IgG, IgM, and IgG1-G4 antibodies in relation to clinical disease. J Neurol Sci 1993 0.75
111 Intra-abdominal abscess in a patient with tumour necrosis factor receptor-associated periodic syndrome. J Intern Med 2006 0.75
112 Seropositivity to LAV/HTLV-III in 11 European countries. Eur J Cancer Clin Oncol 1986 0.75
113 Acquired immune deficiency syndrome. The first cases in Finland. Ann Clin Res 1983 0.75
114 HIV antibodies in laboratory control and calibration sera. Scand J Infect Dis 1989 0.75
115 Fine specificity of the B-cell epitopes recognized in HIV-1 NEF by human sera. Virology 1992 0.75
116 Chromosomally clonal T cells in the skin, blood, or lymph nodes of two Sezary syndrome patients express CD45RA, CD45RO, CDw150, and interleukin-4, but no interleukin-2 or interferon-gamma. J Invest Dermatol 2001 0.75
117 Histochemical identification of human T lymphocytes from paraffin sections. J Histochem Cytochem 1980 0.75
118 [AIDS--the first cases in Finland]. Duodecim 1984 0.75
119 Immunohistological evaluation of alopecia areata treated with squaric acid dibutylester (SADBE). Acta Derm Venereol 1986 0.75
120 Modification of lymphocyte subsets in Jessner's lymphocytic infiltration of the skin during proquazone treatment. Dermatologica 1988 0.75
121 Clinical and immunological findings in HTLV-III infection. Cancer Res 1985 0.75
122 [AIDS prevention and treatment]. Duodecim 1986 0.75
123 [In-situ hybridization in the diagnosis of, and carbon dioxide laser treatment of penile HPV infections]. Duodecim 1993 0.75
124 Comparison of four in situ hybridization methods, based on digoxigenin- and biotin-labelled probes, in detecting HPV DNA in male condylomata acuminata. Int J STD AIDS 1992 0.75
125 Inflammatory cells in skin lesions of scabies. Clin Exp Dermatol 1984 0.75
126 European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: HIV infection. Eur J Dermatol 2008 0.75
127 Treatment of vitiligo with oral methoxsalen and UVA. Photodermatol 1984 0.75
128 A commercial histamine release test and autologous serum skin test in the diagnosis of autoimmune urticaria. Allergy 2006 0.75
129 Immune functions in HTLV-III antibody positive homosexual men without clinical AIDS. Lancet 1984 0.75